INNOVADERM CRO IS NOW INDERO.

Late Phase Studies

Indero supports late stage clinical development, empowering dermatology and rheumatology researchers to demonstrate efficacy and safety through phase IIb-III studies.

Manage Costs & Mitigate Risks With Late Phase Clinical Research

Indero’s dermatology and rheumatology experts evaluate protocol and recruitment objectives to ensure the successful execution of late phase trials. With extensive site connections across the globe and the ability to handle large, multicenter studies, Indero can get your study where it needs to go – meeting your timelines and quality requirements.

Late Phase Study Capabilities

Late phase studies provide critical insights into long-term safety, efficacy, and real-world applications, ensuring treatments meet regulatory and patient needs. Indero’s extensive experience in dermatology and rheumatology trials and deep understanding of immune-mediated conditions positions us as a trusted partner for late phase studies at scale.

Project Management

Our project managers have extensive dermatology and rheumatology experience in all phases of clinical trials, offering leadership and support to sponsors at every stage.

Site Network

We have strong relationships with sites across the world that can meet your requirements for everything from recruitment and retention to timelines and quality.

Innovative Patient Recruitment

We have a dedicated patient recruitment and advertising team working alongside our project management team to build innovative strategies specifically customized for your late phase clinical trials.

Clinical Monitoring

Indero has a team of Clinical Research Associates (CRAs) with capabilities to support all sites in North America, Europe, Latin America and Asia Pacific. This allows us to rapidly assemble a flexible monitoring team depending on site location, project needs and monitoring plan requirements.

Geographical Footprint

Indero’s integrated services span the entire world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Wherever you need to take your trial to ensure genetic diversity among subjects, we can support you.

Biometrics

Indero uses validated and robust in-house data management systems to deliver customized biometrics services. We focus on understanding the sponsor’s goals and study objectives, which ensures the ideal methods for data collection and analysis.

Late Phase Study Services

Late phase clinical trials help dermatology and rheumatology researchers assess the market readiness of new treatments and monitor for potential long-term side effects at scale. Indero specializes in delivering comprehensive solutions for late phase trials, providing robust evidence of a drug’s efficacy and safety in a diverse patient population. Our services include:

  • Late phase study design
  • Site selection & management
  • Patient recruitment
  • Project management 
  • Regulatory & clinical development consulting
  • Clinical monitoring
  • Biostatistics & data management
  • Medical writing
  • Medical monitoring
  • Pharmacovigilance
  • Quality assurance

Snehal Naik, PhD

Senior Vice President,
Clinical Development

ventyx biosciences logo

“The expertise and motivation Indero brought to the table were pivotal to our success. From the initial synopsis development to the final stages of study conduct, the synergy between our teams was palpable and was underpinned by Innovaderm’s strong relationships with sites, investigators, and KOLs.”

 Dermatology & Rheumatology Indications for Late Phase Studies

Indero can support late phase studies across a wide range of dermatology & rheumatology indications, including:

  • Atopic dermatitis
  • Psoriasis
  • Alopecia areata
  • Hidradenitis suppurativa
  • Chronic inducible urticaria
  • Chronic spontaneous urticaria
  • Vitiligo
  • Acne
  • Rosacea
  • Chronic hand eczema
  • Notalgia paresthetica
  • Actinic keratosis
  • GPP, PPP and PPPP
  • Hyperhidrosis
  • Prurigo nodularis
  • Onychomycosis
  • Cosmetics and aesthetics
  • Rheumatoid arthritis
  • Osteoarthritis
  • Radiographic (ankylosing spondylitis) and non-radiographic axial spondyloarthritis
  • Psoriatic arthritis
  • Systemic lupus erythematosus (SLE) and juvenile SLE
  • Lupus nephritis
  • Idiopathic inflammatory myopathies, including polymyositis and dermatomyositis
  • Sjögren’s disease
  • Systemic sclerosis (scleroderma)
  • Osteoporosis

Atopic Dermatitis Phase III Study Reaches 200% Enrollment within First 5 Months

Indero successfully managed a Phase III atopic dermatitis program testing a topical treatment, which included four studies across the USA, Canada and Europe.

Challenges

  • Site selection: 
    • Very competitive and saturated indication in North America
  • Recruitment: 
    • Recruitment slowed down after open-label extension (OLE) enrollment was completed
  • Photography:
    • Material shipment and site training impacted site’s activation timelines

Strategy

  • Evaluated expansion in other regions than North America
  • Supplement site recruitment activities with substantial digital central advertisement programs
  • Conducted follow-up with sites to ensure photograph training was completed on schedule
  • Shipped photography material in conjunction with site contract signature for a streamlined activation timeline

Wherever You’re Going, We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.